For children aged 4 through 17
The first and only FDA-approved treatment for peanut allergy

HELP CONTROL THEIR REACTIONS, SO THEY'RE NOT CONTROLLED BY THEM

Get Started

Aimmune is ready to help you get started

Talk to one of our Aimmune Allergy Account Managers today.

Get in Touch

PROVEN IN A CLINICAL TRIAL TO REDUCE THE SEVERITY OF ALLERGIC REACTIONS THAT MAY OCCUR WITH ACCIDENTAL EXPOSURE TO PEANUT

See more about the efficacy and safety of PALFORZIA.

Pivotal Key Studies
Pre-packaged dosing icon

Standardized, prepackaged DOSING for in‑office and at‑home administration

View dosing chart and additional guidance for in-clinic and at-home dosing.

Dosing

GET STARTED WITH PALFORZIA

Follow this guidance to help your practice.

Get Started

Support to help your patients get ready for PALFORZIA

PALFORZIA Pathway logo

PALFORZIA Pathway can help your patients with access, coverage, and reimbursement needs, while our broad range of educational resources can help support your patients.

Palforzia Pathway

References

  1. PALFORZIA [package insert]. Brisbane, CA: Aimmune Therapeutics, Inc.